Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matrosova, V. Y.
Right arrow Articles by Khaldoyanidi, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matrosova, V. Y.
Right arrow Articles by Khaldoyanidi, S. K.

Stem Cells 2004;22:544-555 www.StemCells.com
© 2004 AlphaMed Press

Hyaluronic Acid Facilitates the Recovery of Hematopoiesis following 5-Fluorouracil Administration

Vera Y. Matrosovaa, Irina A. Orlovskayab, Naira Serobyanc, Sophia K. Khaldoyanidic

a National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland;
b Institute for Clinical Immunology, Novosibirsk, Russia;
c Division of Vascular Biology, La Jolla Institute for Molecular Medicine, San Diego, California, USA

Key Words. Bone marrow aplasia • Chemotheraphy • Cytokines • Hematopoietic progenitor cells Microenvironment • Hyaluronan

Correspondence: Sophia K. Khaldoyanidi, M.D., Ph.D., Division of Vascular Biology, La Jolla Institute for Molecular Medicine, 4570 Executive Drive, Suite 100, San Diego, CA 92121, USA. Telephone: 858-587-8788 ext. 105; Fax: 858-587-6742; e-mail: sophia{at}ljimm.org

The fate of hematopoietic stem cells (HSCs) is determined by microenvironmental niches, but the molecular structure of these local networks is not yet completely characterized. Our recent observation that glycosaminoglycan hyaluronic acid (HA), a major component of the bone marrow extracellular matrix, is required for in vitro hematopoiesis led us to suggest a role for HA in structuring the hematopoietic niche. Accordingly, HA deprivation induced by various treatments might lead to an imbalance of normal HSC homeostasis. Since 5-fluorouracil (5-FU) administration sharply decreases the amount of cell surface–associated HA in bone marrow, we examined whether the administration of exogenous HA enhances suppressed hematopoiesis in 5-FU–treated mice. HA administered to mice following 5-FU infusion facilitated the recovery of leukocytes and thrombocytes in the peripheral blood. Intravenously infused HA was found in the bone marrow, where it bound endothelial cells and resident macrophages and increased expression of the hematopoiesis-supportive cytokines interleukin-1 and interleukin-6. In agreement with these observations, enhanced hematopoietic activity was detected in the bone marrow, as measured by elevated counts of long-term culture-initiating cells (LTC-ICs), committed progenitors, and the total number of mature bone marrow cells. Overall, our results suggest that HA is required for regulation of the hematopoiesis-supportive function of bone marrow accessory cells and, therefore, participates in hematopoietic niche assembly.




This article has been cited by other articles:


Home page
BloodHome page
A. Wimmer, S. K. Khaldoyanidi, M. Judex, N. Serobyan, R. G. DiScipio, and I. U. Schraufstatter
CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes
Blood, December 1, 2006; 108(12): 3722 - 3729.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2004 by AlphaMed Press.